Specific niche view of the structured sector hierarchy. Useful for precedent work where broader sector slices include too much noise.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| Raghava Life Sciences API and intermediates business | RPG Active Pharma | Generic Pharmaceuticals | $18.1M | 5× – 7× | |
| Baihua Pharmaceutical | Jinhua Juxin (Jinhua State-owned Assets Supervision and Administration Commission) | Generic Pharmaceuticals | $2.0M – $2.7M | 5× – 7× | |
| Portfolio of US-marketed generic and specialty pharmaceutical products | The J. Molner Company OU | Generic Pharmaceuticals | $52.0M – $70.0M | 6× – 8× | |
| Apotex Health Corp. | Undisclosed | Generic Pharmaceuticals | $1,300M | 11× – 13× | |
| Goldline Pharmaceutical | Undisclosed | Generic Pharmaceuticals | $1.4M | 9× – 11× | |
| Philippines arm | Lupin | Generic Pharmaceuticals | $39.6M | 9× – 11× | |
| TicTac and Gamez | Nazara Gaming | Generic Pharmaceuticals | $100M | 10× – 12× | |
| ICICI Prudential Life Insurance | Prudential plc | Generic Pharmaceuticals | $100M | 9× – 11× | |
| Sai Parenteral | Undisclosed | Generic Pharmaceuticals | $32.0M – $38.0M | 10× – 12× | |
| Just-Evotec Biologics’ site and in-house development and manufacturing capabilities | Sandoz | Generic Pharmaceuticals | $250M | 10× – 11× |
Bins are observed deal frequencies across disclosed transactions. Use as a directional reference, not a target valuation.
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.